Characterization of in vitro and in vivo Antiviral Activity of Lactoferrin and Ribavirin upon Hantavirus.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Mechanisms of anti-hantaviral activities of bovine lactoferrin (LF) and ribavirin (Rbv) were investigated. Hantavirus focus formation at 48 hr was 15% of the control in cells treated with 400 microg/ml LF for 1 hr at 37 degrees C prior to viral infection. Post infection treatment with 100 microg/ml Rbv also inhibited the focus formation to 2.5% of the control. Combined LF pre- and Rbv post-infection treatment completely inhibited focus formation. Viral glycoprotein (G2) and nucleocapsid protein (NP) syntheses were delayed in LF pretreated cells up to 24 hr post infection (hpi) but became comparable to the control by 48 hpi. Further, LF inhibited viral shedding at 24 hpi but did not inhibit shedding after 48 hpi. However, Rbv was able to inhibit synthesis of viral proteins, (+) and (-) strand RNAs also inhibited viral shedding after 24 hr. These results suggest that LF inhibits viral adsorption to cells, while Rbv inhibits viral RNA synthesis. For in vivo trials of LF and Rbv, LF pre- and Rbv post-treatment were evaluated in suckling mice infected with hantavirus, of which 7% survived. LF concentrations of 40 and 160 mg/kg administered prior to viral challenge improved survival rates to 15% and 70%, respectively for single administration and 85% and 94%, respectively, for double administration. Rbv concentrations of 25 and 50 mg/kg gave survival rates of 68% and 81%, respectively. This suggests that both LF and Rbv are efficacious in hantavirus infection in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
Yamauchi, K., Tomita, M., Giehl, T. J., & Ellison, R. T. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.719-728.1993 · Cited by 500
Harmsen, M. C., Swart, P. J., Bethune, M.-P. D., Pauwels, R., Clercq, E. D., The, T. B., & Meijer, D. K. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.380 · Cited by 379
Ikeda, M., Nozaki, A., Sugiyama, K., Tanaka, T., Naganuma, A., Tanaka, K., Sekihara, H., Shimotohno, K., Saito, M., & Kato, N. (2000) · Virus Research · doi:10.1016/s0168-1702(99)00121-5 · Cited by 149
Cited by
Antiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356
“These results suggested that both lactoferrin and Rbv were efficacious in the treatment of hantavirus infection in vivo [114].”
BackgroundResultFischer, R., Debbabi, H., Dubarry, M., Boyaka, P., & Tomé, D. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-058 · Cited by 104
“2003), viral (Murphy et al. 2001), parasitic (Tanaka et al.”
Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies
Gowen, B. B., & Hickerson, B. T. (2017) · Journal of Microbiology · doi:10.1007/s12275-017-7029-8 · Cited by 26
Milk Derived Peptides with Immune Stimulating Antiviral Properties
Sun, H., & Jensse, H. (2012) · Milk Protein · doi:10.5772/50158 · Cited by 12
Metadata
- Authors
- Murphy, M. E., Kariwa, H., Mizutani, T., Tanabe, H., Yoshimatsu, K., Arikawa, J., & Takashima, I.
- Venue
- Journal of Veterinary Medical Science
- Published
- 2001
- Volume
- 63
- Issue
- 6
- Pages
- 637-645
- ISSN
- 0916-7250 (ISSN-L)
- 1347-7439
- OpenAlex
- W2038160938
- Cited by
- 57
- References
- 3
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of in vitro and in vivo Antiviral Activity of Lactoferrin and Ribavirin upon Hantavirus. https://app.cochat.ai/papers/10.1292/jvms.63.637
- The paper
- Murphy, M. E., Kariwa, H., Mizutani, T., Tanabe, H., Yoshimatsu, K., Arikawa, J., & Takashima, I. (2001). Characterization of in vitro and in vivo Antiviral Activity of Lactoferrin and Ribavirin upon Hantavirus. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.63.637
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.